The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances

Journal of Neurochemistry

Volumn 121, Issue 1, 2012, Pages 99-114

  Fournet, Vincent ^a   Schweitzer, Annie ^a   Chevarin, Caroline ^b   Deloulme, Jean Christophe ^a   Hamon, Michel ^b   Giros, Bruno ^a   Andrieux, Annie ^a   Martres, Marie Pascale ^a  

^a INSERM   (France)

^b CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

Author keywords

antidepressants; anxiety depression; cognitive performance; knockout mice; norepinephrine serotonin transporters; schizoaffective disorders

Indexed keywords

DOPAMINE; MICROTUBULE ASSOCIATED PROTEIN; NORADRENALIN; NORADRENALIN TRANSPORTER; SEROTONIN; SEROTONIN TRANSPORTER; STABLE TUBULE ONLY POLYPEPTIDE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HOPELESSNESS; KNOCKOUT MOUSE; MENTAL PERFORMANCE; MOOD DISORDER; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RAPHE NUCLEUS; SHORT TERM MEMORY; TASK PERFORMANCE; TISSUE DISTRIBUTION; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; FEMALE; GENE DELETION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MOOD DISORDERS; NERVE TISSUE PROTEINS;

MUS;

EID: 84858635137     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07615.x     Document Type: Article

References (89)

1. Alexandre C., Popa D., Fabre V., Bouali S., Venault P., Lesch K. P., Hamon M., and, Adrien J., (2006) Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J. Neurosci. 26, 5554-5564. (Pubitemid 44318406)
2. Andrieux A., Salin P. A., Vernet M., et al. (2002) The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev. 16, 2350-2364. (Pubitemid 35034405)
3. Andrieux A., Salin P., Schweitzer A., et al. (2006) Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia. Biol. Psychiatry 60, 1224-1230. (Pubitemid 44693534)
4. Ansorge M. S., Morelli E., and, Gingrich J. A., (2008) Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J. Neurosci. 28, 199-207.
5. Ase A. R., Reader T. A., Hen R., Riad M., and, Descarries L., (2001) Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. J. Neurochem. 78, 619-630. (Pubitemid 32729990)
6. Ayhan Y., Abazyan B., and, Nomura J., et al. (2010) Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry. 16, 293-306.
7. Beaulieu J. M., Zhang X., Rodriguiz R. M., Sotnikova T. D., Cools M. J., Wetsel W. C., Gainetdinov R. R., and, Caron M. G., (2008) Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. USA 105, 1333-1338. (Pubitemid 351397053)
8. Begou M., Brun P., Bertrand J. B., Job D., Schweitzer A., D'Amato T., Saoud M., Andrieux A., and, Suaud-Chagny M. F., (2007) Post-pubertal emergence of alterations in locomotor activity in stop null mice. Synapse 61, 689-697. (Pubitemid 47122740)
9. Begou M., Volle J., Bertrand J. B., et al. (2008) The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics. Neuroscience 157, 29-39.
10. Belzung C., (2001) The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models. Behav. Pharmacol. 12, 451-460. (Pubitemid 33152268)
11. Bevins R. A., and, Besheer J., (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat. Protoc. 1, 1306-1311.
12. Blackwood D., Pickard B., Thomson P., Evans K., Porteous D., and, Muir W., (2007) Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotox. Res. 11, 73-83.
13. Bouvrais-Veret C., Weiss S., Andrieux A., Schweitzer A., McIntosh J. M., Job D., Giros B., and, Martres M. P., (2007) Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice. Neuropharmacology 52, 1691-1700. (Pubitemid 46850753)
14. Bouvrais-Veret C., Weiss S., Hanoun N., Andrieux A., Schweitzer A., Job D., Hamon M., Giros B., and, Martres M. P., (2008) Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. J. Neurochem. 104, 745-756.
15. Brenner E., Sonnewald U., Schweitzer A., Andrieux A., and, Nehlig A., (2007) Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia. J. Neurosci. Res. 85, 3487-3493. (Pubitemid 350058536)
16. Brown R., and, Silva A. J., (2004) Molecular and cellular cognition; the unraveling of memory retrieval. Cell 117, 3-4. (Pubitemid 38469892)
17. Brun P., Begou M., Andrieux A., et al. (2005) Dopaminergic transmission in STOP null mice. J. Neurochem. 94, 63-73. (Pubitemid 40911393)
18. Callicott J., Straub R., Pezawas L., et al. (2005) Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl Acad. Sci. USA 102, 8627-8632. (Pubitemid 40862786)
19. Camargo L. M., Collura V., Rain J. C., Mizuguchi K., Hermjakob H., Kerrien S., Bonnert T. P., Whiting P. J., and, Brandon N. J., (2007) Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 12, 74-86. (Pubitemid 44973664)
20. Cardno A. G., Marshall E. J., Coid B., et al. (1999) Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 56, 162-168. (Pubitemid 29081391)
21. Carpenter W. T., Bustillo J. R., Thaker G. K., van Os J., Krueger R. F., and, Green M. J., (2009) The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. Psychol. Med. 39, 2025-2042.
22. Chen K., Holschneider D. P., Wu W., Rebrin I., and, Shih J. C., (2004) A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J. Biol. Chem. 279, 39645-39652. (Pubitemid 39258232)
23. Clapcote S. J., Lipina T. V., Millar J. K., et al. (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54, 387-402. (Pubitemid 46671409)
24. Craddock N., and, Owen M. J., (2005) The beginning of the end for the Kraepelinian dichotomy. Br. J. Psychiatry 186, 364-366. (Pubitemid 40663416)
25. Craddock N., O'Donovan M. C., and, Owen M. J., (2006) Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bull. 32, 9-16. (Pubitemid 43063811)
26. Delagrange P., Misslin R., Seale T. W., Pfeiffer B., Rault S., and, Renard P., (1999) Effects of S-21007, a potent 5-HT3 partial agonist, in mouse anxiety. Zhongguo Yao Li Xue Bao 20, 805-812. (Pubitemid 29459746)
27. Delotterie D., Ruiz G., Brocard J., Schweitzer A., Roucard C., Roche Y., Suaud-Chagny M. F., Bressand K., and, Andrieux A., (2010) Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice. Psychopharmacology (Berl), 208 131-141.
28. Deltheil T., Guiard B. P., Cerdan J., et al. (2008) Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 55, 1006-1014.
29. Desbonnet L., Waddington J. L., and, Tuathaigh C. M., (2009) Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes? Behav. Brain Res., 204 258-273.
30. Detke M. J., Rickels M., and, Lucki I., (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121, 66-72.
31. Dziedzicka-Wasylewska M., Faron-Gorecka A., Kusmider M., Drozdowska E., Rogoz Z., Siwanowicz J., Caron M. G., and, Bonisch H., (2006) Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 31, 2424-2432. (Pubitemid 44607060)
32. Eastwood S. L., Lyon L., George L., Andrieux A., Job D., and, Harrison P. J., (2007) Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice. J. Psychopharmacol. 21, 635-644. (Pubitemid 47472734)
33. El-Ghundi M., O'Dowd B. F., and, George S. R., (2007) Insights into the role of dopamine receptor systems in learning and memory. Rev. Neurosci. 18, 37-66.
34. Fabre V., Beaufour C., Evrard A., et al. (2000) Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12, 2299-2310. (Pubitemid 30497028)
35. Fournet V., Jany M., Fabre V., et al. (2010) The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. J. Neurochem. 115, 1579-1594.
36. Fradley R. L., O'Meara G. F., Newman R. J., Andrieux A., Job D., and, Reynolds D. S., (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav. Brain Res. 163, 257-264. (Pubitemid 41138060)
37. Franklin K. B., and, Paxinos G., (1997) The Mouse Brain in Stereotaxic Coordinates, Academic Press, Inc., San Diego, CA, USA.
38. Franowicz J. S., Kessler L. E., Borja C. M., Kobilka B. K., Limbird L. E., and, Arnsten A. F., (2002) Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J. Neurosci. 22, 8771-8777. (Pubitemid 35387619)
39. Fukui M., Rodriguiz R. M., Zhou J., Jiang S. X., Phillips L. E., Caron M. G., and, Wetsel W. C., (2007) Vmat2 heterozygous mutant mice display a depressive-like phenotype. J. Neurosci. 27, 10520-10529. (Pubitemid 47502010)
40. Gonzalez-Burgos I., and, Feria-Velasco A., (2008) Serotonin/dopamine interaction in memory formation. Prog. Brain Res. 172, 603-623.
41. Gras C., Amilhon B., Lepicard E. M., et al. (2008) The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat. Neurosci. 11, 292-300. (Pubitemid 351311799)
42. Griebel G., Rodgers R. J., Perrault G., and, Sanger D. J., (2000) The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Neuropharmacology 39, 1848-1857. (Pubitemid 30398488)
43. Gross C., Zhuang X., Stark K., Ramboz S., Ronald O., Kirby L., Santarelli L., Beck S., and, Hen R., (2002) Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416, 396-400. (Pubitemid 34272867)
44. Hanaya R., Koning E., Ferrandon A., Schweitzer A., Andrieux A., and, Nehlig A., (2008) Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice. J. Neurosci. Res. 86, 813-820. (Pubitemid 351357762)
45. Holmes A., Murphy D. L., and, Crawley J. N., (2003) Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 54, 953-959. (Pubitemid 37415031)
46. Jenkins T. A., Elliott J. J., Ardis T. C., Cahir M., Reynolds G. P., Bell R., and, Cooper S. J., (2010) Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone. Behav. Brain Res. 208, 479-483.
47. Jennings K. A., Loder M. K., Sheward W. J., et al. (2006) Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J. Neurosci. 26, 8955-8964. (Pubitemid 44319384)
48. Ji Y., Yang F., Papaleo F., Wang H. X., Gao W. J., Weinberger D. R., and, Lu B., (2009) Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc. Natl. Acad. Sci. USA 106, 19593-19598.
49. Kajitani K., Thorne M., Samson M., and, Robertson G. S., (2010) Nitric oxide synthase mediates the ability of darbepoetin alfa to improve the cognitive performance of STOP null mice. Neuropsychopharmacology 35, 1718-1728.
50. Kalueff A. V., Fox M. A., Gallagher P. S., and, Murphy D. L., (2007) Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav. 6, 389-400. (Pubitemid 46800538)
51. Kalueff A. V., Olivier J. D., Nonkes L. J., and, Homberg J. R., (2010) Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci. Biobehav. Rev. 34, 373-386.
52. Kessler R. C., Chiu W. T., Demler O., Merikangas K. R., and, Walters E. E., (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617-627. (Pubitemid 40973437)
53. Kim D.-K., Tolliver T. J., Huang S.-J., Martin B. J., Andrews A. M., Wichems C. H., Holmes A., Lesch K.-P., and, Murphy D. L., (2005) Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49, 798-810. (Pubitemid 41483886)
54. Kokkinidis L., and, Anisman H., (1976) Dissociation of the effects of scopolamine and d-amphetamine on a spontaneous alternation task. Pharmacol. Biochem. Behav. 5, 293-297.
55. Kusserow H., Davies B., Hortnagl H., et al. (2004) Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. Brain Res. Mol. Brain Res. 129, 104-116. (Pubitemid 39304254)
56. Kvajo M., McKellar H., Arguello P. A., Drew L. J., Moore H., MacDermott A. B., Karayiorgou M., and, Gogos J. A., (2008) A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. USA 105, 7076-7081. (Pubitemid 351754532)
57. Lanfumey L., Mongeau R., Cohen-Salmon C., and, Hamon M., (2008) Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci. Biobehav. Rev. 32, 1174-1184.
58. Lieberman J. A., Perkins D., Belger A., Chakos M., Jarskog F., Boteva K., and, Gilmore J., (2001) The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol. Psychiatry 50, 884-897. (Pubitemid 34023591)
59. Line S. J., Barkus C., Coyle C., Jennings K. A., Deacon R. M., Lesch K. P., Sharp T., and, Bannerman D. M., (2010) Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice. Eur. Neuropsychopharmacol. 21, 108-116.
60. Lira A., Zhou M., Castanon N., et al. (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54, 960-971. (Pubitemid 37415032)
61. Maier W., Zobel A., and, Wagner M., (2006) Schizophrenia and bipolar disorder: differences and overlaps. Curr. Opin. Psychiatry 19, 165-170. (Pubitemid 44406128)
62. Masse F., Petit-Demouliere B., Dubois I., Hascoet M., and, Bourin M., (2008) Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test. Behav. Brain Res. 188, 291-297.
63. Merenlender-Wagner A., Pikman R., Giladi E., Andrieux A., and, Gozes I., (2010) NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse - a microtubule-deficient model of schizophrenia. Peptides 31, 1368-1373.
64. Millan M. J., Dekeyne A., Papp M., La Rochelle C. D., MacSweeny C., Peglion J. L., and, Brocco M., (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J. Pharmacol. Exp. Ther. 298, 581-591. (Pubitemid 32673408)
65. Mirnics K., Middleton F. A., Lewis D. A., and, Levitt P., (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24, 479-486. (Pubitemid 32695360)
66. Morice E., Billard J.-M., Denis C., Mathieu F., Betancur C., Epelbaum J., Giros B., and, Nosten-Bertrand M., (2007) Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology 32, 2108-2116. (Pubitemid 47417702)
67. Morris J., Kandpal G., Ma L., and, Austin C., (2003) DISC1(disrupted-in- schizophrenia 1) is a centrosome-assciated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss if interaction with mutation. Hum. Mol. Genet. 12, 1591-1608. (Pubitemid 36857306)
68. Murray R. M., Sham P., Van Os J., Zanelli J., Cannon M., and, McDonald C., (2004) A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Res. 71, 405-416. (Pubitemid 39330519)
69. Nieoullon A., (2002) Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67, 53-83. (Pubitemid 34786170)
70. Niwa M., Kamiya A., Murai R., et al. (2010) Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 65, 480-489.
71. Olivier J. D., Van Der Hart M. G., Van Swelm R. P., et al. (2008) A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152, 573-584.
72. Ordway G. A., Stockmeier C. A., Cason G. W., and, Klimek V., (1997) Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J. Neurosci. 17, 1710-1719. (Pubitemid 27089816)
73. Perona M. T., Waters S., Hall F. S., Sora I., Lesch K. P., Murphy D. L., Caron M., and, Uhl G. R., (2008) Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav. Pharmacol. 19, 566-574.
74. Pletnikov M., Ayhan Y., Nicholskaia O., Ovanesov M., Huang H., Mori S., Moran T., and, Ross C., (2008) Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry 13, 173-186.
75. Popa D., Léna C., Alexandre C., and, Adrien J., (2008) Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress and behavior. J. Neurosci. 28, 3546-3554.
76. Porsolt R. D., Bertin A., Blavet N., Deniel M., and, Jalfre M., (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57, 201-210. (Pubitemid 9250881)
77. Porteous D. J., and, Millar J. K., (2006) Disrupted in schizophrenia 1: building brains and memories. Trends Mol. Med. 12, 255-261. (Pubitemid 43870434)
78. Powell K. J., Hori S. E., Leslie R., Andrieux A., Schellinck H., Thorne M., and, Robertson G. S., (2007) Cognitive impairments in the STOP null mouse model of schizophrenia. Behav. Neurosci. 121, 826-835. (Pubitemid 350064351)
79. Radomsky E. D., Haas G. L., Mann J. J., and, Sweeney J. A., (1999) Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am. J. Psychiatry 156, 1590-1595. (Pubitemid 29459992)
80. Richardson-Jones J. W., Craige C. P., Nguyen T. H., et al. (2011) Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J. Neurosci. 31, 6008-6018.
81. Ross C. A., Margolis R. L., Reading S. A., Pletnikov M., and, Coyle J. T., (2006) Neurobiology of schizophrenia. Neuron 52, 139-153. (Pubitemid 44466356)
82. Savelieva K. V., Zhao S., Pogorelov V. M., Rajan I., Yang Q., Cullinan E., and, Lanthorn T. H., (2008) Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS ONE 3, e3301.
83. Schaefer T. L., Vorhees C. V., and, Williams M. T., (2009) Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness. Neuroscience 164, 1431-1443.
84. Spielewoy C., Roubert C., Hamon M., Nosten-Bertrand M., Betancur C., and, Giros B., (2000) Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav. Pharmacol. 11, 279-290. (Pubitemid 30449759)
85. Talbot K., (2009) The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research. Prog. Brain Res. 179, 87-94.
86. Talbot K., Cho D. S., Ong W. Y., et al. (2006) Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum. Mol. Genet. 15, 3041-3054. (Pubitemid 44530708)
87. Weiss S., Nosten-Bertrand M., McIntosh J. M., Giros B., and, Martres M. P., (2007) Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacology 32, 2465-2478. (Pubitemid 350126838)
88. Willner P., (1991) Animal models as simulations of depression. Trends Pharmacol. Sci. 12, 131-136.
89. Yalcin I., Belzung C., and, Surget A., (2008) Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey. Behav. Brain Res. 193, 140-143.